Fidelity International’s West Pharmaceutical WST Stock Holding History

Fidelity International’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.27M	Sell	23,044 -2,395	-9%	-$732K	0.01%	615
2026 Q1	$6.38M	Sell	25,439 -26,906	-51%	-$6.69M	0.01%	654
2025 Q4	$14.4M	Buy	52,345 +656	+1%	+$179K	0.01%	529
2025 Q3	$13.6M	Buy	51,689 +51,088	+8,500%	+$12.4M	0.01%	526
2025 Q2	$131K	Sell	601 -5,339	-90%	-$1.14M	﹤0.01%	915
2025 Q1	$1.33M	Hold	5,940	–	–	﹤0.01%	708
2024 Q4	$1.95M	Sell	5,940 -26,415	-82%	-$8.31M	﹤0.01%	685
2024 Q3	$9.71M	Sell	32,355 -26,888	-45%	-$8.23M	0.01%	554
2024 Q2	$19.5M	Buy	59,243 +2,960	+5%	+$1.05M	0.02%	448
2024 Q1	$22.3M	Hold	56,283	–	–	0.02%	425
2023 Q4	$19.8M	Buy	+56,283	New	+$19.9M	0.02%	420
2021 Q2	–	Sell	-7	Closed	-$2K	–	1109
2021 Q1	$2K	Hold	7	–	–	﹤0.01%	877
2020 Q4	$2K	Buy	7 +1	+17%	+$281	﹤0.01%	845
2020 Q3	$2K	Sell	6 -3	-33%	-$794	﹤0.01%	845
2020 Q2	$2K	Buy	+9	New	+$1.77K	﹤0.01%	824
2018 Q1	–	Sell	-94,436	Closed	-$9.32M	–	538
2017 Q4	$9.32M	Buy	+94,436	New	+$9.26M	0.03%	359

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity International's WST Position: Q2 2026 in Review

Fidelity International reduced its West Pharmaceutical (WST) stake by 9.4% in Q2 2026, selling an estimated $732K and leaving 23,044 shares worth $8.27M. The position accounts for 0.01% of the portfolio, ranked #615.

Fidelity International first reported a position in WST in Q4 2017 and has held it in 16 quarters since. The position peaked at $22.3M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Fidelity International held 23,044 shares of West Pharmaceutical worth $8.27M as of Q2 2026.
Fidelity International sold 2,395 West Pharmaceutical shares in Q2 2026, an estimated $732K.
West Pharmaceutical made up 0.01% of Fidelity International's portfolio in Q2 2026, its #615 holding.
Fidelity International first reported a position in West Pharmaceutical in Q4 2017 and has held it in 16 quarters since.
Fidelity International's West Pharmaceutical position peaked at $22.3M in Q1 2024.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.